Resources2025-04-28T07:08:32+00:00

Resources

WHITE PAPERS

Precision Perfected: Elevating Aesthetic Outcomes with MicronJetTM’s Advanced Technology

Nanopass brochure update white paper

The Future of Virtually Pain-Free Injections
 

Media Coverage

NanoPass developed the smallest FDA-approved microneedle

Published in TechTime. The needle, less than 1 millimeter, is manufactured using MEMS technology. It is intended for vaccines and painless medicines injection. The company announced production agreement with Korean M2N.

Nanopass' intradermal device is ready for commercialization with Vaccines ( Kan 11 TV channel)

Israel's national broadcast service (Kan 11) interviewed Nanopass Technologies on its intradermal platform for its daily financial TV show.
Go to Top